Steven Degrijse
SDegrijse
$KPTI Commercial stage oncology player, targeting nuclear export in cancer. 1 wholly owned FDA approved drug XPOVIO (selinexor-SELective Inhibitor of NUclear EXport, given ORally, once or twice a week) in
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.